BANK OF MONTREAL /CAN/ - AKCEA THERAPEUTICS INC ownership

AKCEA THERAPEUTICS INC's ticker is AKCA and the CUSIP is 00972L107. A total of 100 filers reported holding AKCEA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.70 and the average weighting 0.1%.

Quarter-by-quarter ownership
BANK OF MONTREAL /CAN/ ownership history of AKCEA THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$118,000
+555.6%
6,510
+393.2%
0.00%
Q2 2020$18,000
-33.3%
1,320
-15.7%
0.00%
Q4 2019$27,000
-60.9%
1,565
-65.2%
0.00%
Q3 2019$69,000
-92.7%
4,491
-88.9%
0.00%
Q2 2019$948,000
-15.1%
40,434
+2.6%
0.00%
Q1 2019$1,116,000
+22220.0%
39,400
+22159.9%
0.00%
Q4 2018$5,000
+66.7%
177
+101.1%
0.00%
Q3 2018$3,000
+50.0%
88
-2.2%
0.00%
Q2 2018$2,000900.00%
Other shareholders
AKCEA THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Bellevue Group AG 3,162,643$53,575,0000.85%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 31,723$536,0000.19%
Amia Capital LLP 28,217$478,0000.14%
Motley Fool Asset Management LLC 60,489$1,025,0000.11%
Virtus ETF Advisers LLC 33,059$560,0000.09%
ALTRINSIC GLOBAL ADVISORS LLC 70,286$1,191,0000.05%
A.R.T. Advisors, LLC 53,560$907,0000.04%
TUDOR INVESTMENT CORP ET AL 46,433$787,0000.04%
Caption Management, LLC 54,000$915,0000.03%
Caption Management, LLC 54,000$915,0000.03%
View complete list of AKCEA THERAPEUTICS INC shareholders